Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$975K Sell
2,692
-59
-2% -$20.2K 0.12% 88
2026
Q1
$968K Buy
2,751
+58
+2% +$20.7K 0.14% 81
2025
Q4
$881K Buy
2,693
+266
+11% +$84.4K 0.13% 90
2025
Q3
$685K Buy
2,427
+40
+2% +$11.6K 0.13% 93
2025
Q2
$666K Sell
2,387
-170
-7% -$48.2K 0.12% 99
2025
Q1
$797K Buy
2,557
+249
+11% +$73.5K 0.17% 93
2024
Q4
$602K Buy
+2,308
New +$685K 0.13% 97

Other funds holding AMGN

IFC Advisors's AMGN Position: Q2 2026 in Review

IFC Advisors reduced its Amgen (AMGN) stake by 2.1% in Q2 2026, selling an estimated $20.2K and leaving 2,692 shares worth $975K. The position accounts for 0.12% of the portfolio, ranked #88.

IFC Advisors first reported a position in AMGN in Q4 2024 and has held it in 7 quarters since. 3,149 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • IFC Advisors held 2,692 shares of Amgen worth $975K as of Q2 2026.
  • IFC Advisors sold 59 Amgen shares in Q2 2026, an estimated $20.2K.
  • Amgen made up 0.12% of IFC Advisors's portfolio in Q2 2026, its #88 holding.
  • IFC Advisors first reported a position in Amgen in Q4 2024 and has held it in 7 quarters since.
  • 3,149 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on IFC Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.